Drug intelligence / Profile preview

Gentamicin + Lincomycin

Development stage
Unknown
Administration
Oral, Intramuscular, Intravenous
01

Overview

Gentamicin + lincomycin is an antibiotic combination that leverages the complementary mechanisms of action of both drugs to provide enhanced antimicrobial coverage. This combination enlarges the antibacterial spectrum and enhances the antibacterial effect of lincomycin[3]. Gentamicin is an aminoglycoside antibiotic effective against both gram-positive and gram-negative bacteria. It works by binding to bacterial ribosomes and inhibiting protein synthesis[10]. Lincomycin is a lincosamide antibiotic primarily effective against gram-positive bacteria including streptococci, pneumococci, and staphylococci, as well as some gram-negative cocci and anaerobic bacteria[2][6]. The combination is particularly useful for treating severe bacterial infections, especially in veterinary medicine where it's used in animal feed and drinking water[5]. The synergistic effect of these antibiotics makes them valuable for treating respiratory, gastrointestinal, and urinary infections, as well as septicemia in domestic animals[5].

02

Targets

Bacterial 50S ribosomal subunitBacterial Ribosome

Beyond the preview

Go deeper on Gentamicin + Lincomycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gentamicin + Lincomycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call